The Hydroponics Company Ltd (THC) provided an update with respect to a revaluation of its Southport pharmaceutical manufacturing facility of $14.58 million with an unmatched domestic manufacturing capability. Independent market valuation of THC's Southport Manufacturing Facility delivers $16.68 million combined asset value to balance sheet. Having secured significant medicinal cannabis growing capability and a manufacturing facility with industry leading capacity, THC has a clear path to a revenue generating medicinal cannabis business in the near term, with the ability to service domestic patients and export into other markets
http://crweworld.com/australia/tren...nce-sheet-ampamp-medicinal-cannabis-strategy-
Ann: Acquisition Delivers $16m to Balance Sheet & MC Strategy, page-14
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable